Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP OPH SOLN 0.25% | 0.25% | LIQUID | Resolved | 2017-03-11 | 2019-01-03 | 513 |
| APO-TIZANIDINE | 4MG | TABLET | Actual shortage | 2025-04-17 | 2025-05-08 | 255208 |
| APO-TOBRAMYCIN | 0.3% | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19123 |
| APO-TOLTERODINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-11-08 | 516 |
| APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2017-11-07 | 519 |
| APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2018-02-28 | 523 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-03-21 | 2017-03-21 | 3746 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2017-04-24 | 2017-07-05 | 7728 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-05-10 | 2017-05-25 | 9957 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-06-13 | 2017-07-11 | 12701 |
| APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2017-09-07 | 2017-10-16 | 21216 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-11-01 | 2018-01-03 | 27767 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2017-12-14 | 2018-03-06 | 32839 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2023-11-06 | 2024-01-05 | 209345 |
| APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2023-11-10 | 2024-01-05 | 209948 |
| APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2018-03-29 | 2018-07-03 | 44200 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2018-05-08 | 2018-07-03 | 48869 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2018-11-09 | 2019-01-17 | 66552 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69324 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2022-01-21 | 2022-02-18 | 153291 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60766 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
| APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2019-02-05 | 60778 |
| APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
| APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
| APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |